Second Financial Statements From 2010 to 2024
| EYESDelisted Stock | USD 4.14 0.20 4.61% |
Check Second Sight financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among Second main balance sheet or income statement drivers, such as , as well as many exotic indicators such as . Second financial statements analysis is a perfect complement when working with Second Sight Valuation or Volatility modules.
Second |
Second Sight Medical Company Shares Outstanding Analysis
Second Sight's Outstanding Shares are shares of common stock of a public company that were purchased by investors after they were authorized and issued by the company to the public. Outstanding Shares are typically reported on fully diluted basis, including exotic instruments such as options, or convertibles bonds.
Current Second Sight Shares Outstanding | 39.41 M |
Most of Second Sight's fundamental indicators, such as Shares Outstanding, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, Second Sight Medical is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.
Outstanding shares that are stated on company Balance Sheet are used when calculating many important valuation and performance indicators including Return on Equity, Market Cap, EPS and many others.
CompetitionBased on the latest financial disclosure, Second Sight Medical has 39.41 M of shares currently outstending. This is 78.17% lower than that of the Healthcare sector and 77.47% lower than that of the Medical Devices industry. The shares outstanding for all United States stocks is 93.11% higher than that of the company.
Second Sight Medical Fundamental Drivers Relationships
Comparative valuation techniques use various fundamental indicators to help in determining Second Sight's current stock value. Our valuation model uses many indicators to compare Second Sight value to that of its competitors to determine the firm's financial worth. You can analyze the relationship between different fundamental ratios across Second Sight competition to find correlations between indicators driving Second Sight's intrinsic value. More Info.Second Sight Medical is one of the top stocks in return on equity category among related companies. It is one of the top stocks in return on asset category among related companies . Comparative valuation analysis is a catch-all model that can be used if you cannot value Second Sight by discounting back its dividends or cash flows. This model doesn't attempt to find an intrinsic value for Second Sight's Stock. Still, instead, it compares the stock's price multiples to a benchmark or nearest competition to determine if the stock is relatively undervalued or overvalued. The reason why the comparable model can be used in almost all circumstances is due to the vast number of multiples that can be utilized, such as the price-to-earnings (P/E), price-to-book (P/B), price-to-sales (P/S), price-to-cash flow (P/CF), and many others. The P/E ratio is the most commonly used of these ratios because it focuses on the Second Sight's earnings, one of the primary drivers of an investment's value.About Second Sight Financial Statements
There are typically three primary documents that fall into the category of financial statements. These documents include Second Sight income statement, its balance sheet, and the statement of cash flows. Second Sight investors use historical funamental indicators, such as Second Sight's revenue or net income, to determine how well the company is positioned to perform in the future. Although Second Sight investors may use each financial statement separately, they are all related. The changes in Second Sight's assets and liabilities, for example, are also reflected in the revenues and expenses that we see on Second Sight's income statement, which results in the company's gains or losses. Cash flows can provide more information regarding cash listed on a balance sheet, but not equivalent to net income shown on the income statement. We offer a historical overview of the basic patterns found on Second Sight Financial Statements. Understanding these patterns can help to make the right decision on long term investment in Second Sight. Please read more on our technical analysis and fundamental analysis pages.
Second Sight Medical Products, Inc. develops, manufactures, and markets implantable visual prosthetics that are intended to deliver artificial vision to blind individuals. The company was founded in 1998 and is headquartered in Sylmar, California. Second Sight operates under Medical Devices classification in the United States and is traded on NAS Exchange. It employs 15 people.
Pair Trading with Second Sight
One of the main advantages of trading using pair correlations is that every trade hedges away some risk. Because there are two separate transactions required, even if Second Sight position performs unexpectedly, the other equity can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Second Sight will appreciate offsetting losses from the drop in the long position's value.Moving together with Second Stock
| 0.78 | MDT | Medtronic PLC Financial Report 23rd of May 2024 | PairCorr |
Moving against Second Stock
| 0.76 | MDH | MDH Acquisition Corp | PairCorr |
| 0.73 | ARTE | Artemis Strategic | PairCorr |
| 0.62 | BSX | Boston Scientific Corp Buyout Trend | PairCorr |
| 0.5 | EW | Edwards Lifesciences Corp Earnings Call Today | PairCorr |
| 0.5 | DXCM | DexCom Inc Earnings Call Today | PairCorr |
The ability to find closely correlated positions to Second Sight could be a great tool in your tax-loss harvesting strategies, allowing investors a quick way to find a similar-enough asset to replace Second Sight when you sell it. If you don't do this, your portfolio allocation will be skewed against your target asset allocation. So, investors can't just sell and buy back Second Sight - that would be a violation of the tax code under the "wash sale" rule, and this is why you need to find a similar enough asset and use the proceeds from selling Second Sight Medical to buy it.
The correlation of Second Sight is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A perfect positive correlation (i.e., a correlation coefficient of +1) implies that as Second Sight moves, either up or down, the other security will move in the same direction. Alternatively, perfect negative correlation means that if Second Sight Medical moves in either direction, the perfectly negatively correlated security will move in the opposite direction. If the correlation is 0, the equities are not correlated; they are entirely random. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.
Correlation analysis and pair trading evaluation for Second Sight can also be used as hedging techniques within a particular sector or industry or even over random equities to generate a better risk-adjusted return on your portfolios.Check out Investing Opportunities to better understand how to build diversified portfolios. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in income. Note that the Second Sight Medical information on this page should be used as a complementary analysis to other Second Sight's statistical models used to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Portfolio Center module to all portfolio management and optimization tools to improve performance of your portfolios.
Other Consideration for investing in Second Stock
If you are still planning to invest in Second Sight Medical check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the Second Sight's history and understand the potential risks before investing.
| Portfolio Backtesting Avoid under-diversification and over-optimization by backtesting your portfolios | |
| Money Flow Index Determine momentum by analyzing Money Flow Index and other technical indicators | |
| Portfolio Suggestion Get suggestions outside of your existing asset allocation including your own model portfolios | |
| Equity Valuation Check real value of public entities based on technical and fundamental data | |
| Price Exposure Probability Analyze equity upside and downside potential for a given time horizon across multiple markets | |
| Portfolio Analyzer Portfolio analysis module that provides access to portfolio diagnostics and optimization engine | |
| Instant Ratings Determine any equity ratings based on digital recommendations. Macroaxis instant equity ratings are based on combination of fundamental analysis and risk-adjusted market performance | |
| Top Crypto Exchanges Search and analyze digital assets across top global cryptocurrency exchanges | |
| Transaction History View history of all your transactions and understand their impact on performance | |
| Sign In To Macroaxis Sign in to explore Macroaxis' wealth optimization platform and fintech modules |